The global smart pills market was valued at USD 1.0 billion in 2025 and is projected to reach USD 1.3 billion in 2026 and USD 4.1 billion by 2034, growing at a CAGR of 18.90% during the forecast period 2026–2034. As providers place greater emphasis on non-invasive monitoring and continuous patient insights, competition is shaped by established participants. Major players operating in the global market include CapsoVision, Inc., Medisafe, Medtronic, Olympus Corporation, and Otsuka Holdings Co., Ltd.

Smart Pills Market Beyond Diagnostics: Monitoring Applications

Beyond imaging, the smart pills market includes vital sign monitoring as one of three application segments, alongside capsule endoscopy and targeted drug delivery. Smart pills are swallowed as capsules with sensors and cameras, require no sedation, and involve little to no recovery time. Traditional endoscopy provides point-in-time diagnosis with limited long-term monitoring capability, whereas smart pills enable continuous data collection and remote patient monitoring for improved patient insights. Non-invasive monitoring is also listed among the drivers and opportunities in the report's market dynamics.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/smart-pills-market

AI Integration Strengthens Remote Patient Monitoring

Polaris Market Research identifies several ways artificial intelligence is influencing the smart pills market:

• Enhanced diagnostics: faster detection of gastrointestinal and internal health conditions.
• Predictive healthcare: AI-based algorithms help predict disease risks and support early intervention through real-time patient data.
• Personalized treatment: analysis of patient-specific data assists personalized therapy decisions.
• Remote patient monitoring: AI integration strengthens remote patient monitoring by providing continuous health insights and alerts.
• Improved data management: processing of large volumes of sensor-generated data.
• Product development: improved sensor design, accuracy, and functionality.

Geriatric Population Fuels Long-Term Demand

The report names the growing geriatric population as a key driving factor. NCBI data indicate that the U.S. population aged 50 and older is expected to rise 61.1%, from 137.2 million in 2020 to 221.1 million by 2050. The number of individuals aged 50 with at least one medical condition is projected to grow by nearly 99.5%, reaching 142.7 million by 2050 from 71.5 million in 2020, while multimorbidity is estimated to increase 91.2%, from 7.8 million to 14.9 million. Global population is also expected to rise from 8 billion to 9.7 billion by 2050. Potential customers for smart pills include individuals with paralysis, immobile patients, and the geriatric population, supporting demand for advanced medical devices that enhance patient convenience.

Medication Adherence Monitoring and Connected Care

In April 2025, Centor launched a smart pill organizer using LTE connectivity for real-time medication adherence monitoring, enabling pharmacies to offer remote care without requiring patient app setup or configuration. The launch reflects the growing role of connectivity in medication management. Advanced drug delivery products are also expected to find a substantial customer base among patients with chronic diseases who require precise medication dosing.

End-Use and Regional Analysis

By end use, the hospitals segment is expected to record the highest CAGR of 19.8% during the forecast period, driven by advanced diagnostic technologies, specialized healthcare professionals, and comprehensive treatment facilities. Smart Pills market north america held the largest regional share of 40.7% in 2025, with growth attributed to healthcare technology advancement, rising colorectal cancer cases, and regulatory approvals for new products. According to the World Health Organization, colorectal cancer ranks as the third most common cancer globally. Asia Pacific is projected to register the highest CAGR of 20.6%, fueled by mandatory healthcare insurance, technological advancements, and a growing prevalence of stomach cancer; global gastric cancer cases exceeded 1 million in 2020, resulting in 769,000 deaths, with higher incidence rates in countries such as Japan, Mongolia, and China.

Competitive Landscape and Outlook

Market leaders are implementing mergers and acquisitions, enhancements to existing devices, promotional initiatives, and technological advancements. The report's Porter's Five Forces analysis rates rivalry among existing firms as high and the threat of new entrants as low, and identifies the high cost of technology as a restraint. For B2B stakeholders, the convergence of vital sign monitoring, AI-enabled analytics, and remote patient monitoring defines the next phase of the smart pills market through 2034.

More Trending Latest Reports By Polaris Market Research:

glp-1-market

air-fryer-market

biostimulants-market

top-10-companies-in-hospital-information-system-software-market-to-know-in-2025

in-vitro-diagnostics-market

automotive-wiring-harness-market

fire-alarm-and-detection-market

semiconductor-manufacturing-equipment-market

engineered-stone-market